Emilio Esteban
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 30
- Lung Cancer Research Studies 27
- Cancer Treatment and Pharmacology 19
- Pulmonary and Respiratory Medicine top 0.5%
- Renal cell carcinoma treatment 44
- Lung Cancer Treatments and Mutations 40
- Lung Cancer Diagnosis and Treatment 19
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 27
- Immunology top 10%
- Molecular Biology top 10%
- Renal and related cancers 20
- Co-authors
- Saulius CicėnasTudor–Eliade CiuleanuBarbara KlughammerLilia StelmakhErzsébet JuhászI. MelezínekWolfram BruggerAleksandra Szczęsna
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Emilio Esteban
154 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Oncology 2.3k
- Pulmonary and Respiratory Medicine 2.6k
- Cancer Research 737
- Immunology 417
- Molecular Biology 1.2k
Countries citing papers authored by Emilio Esteban
This map shows the geographic impact of Emilio Esteban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilio Esteban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilio Esteban more than expected).
Fields of papers citing papers by Emilio Esteban
This network shows the impact of papers produced by Emilio Esteban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilio Esteban. The network helps show where Emilio Esteban may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emilio Esteban, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 9 | |
| 7 | 2022 | 26 | |
| 8 | 2022 | 5 | |
| 9 | 2019 | 3 | |
| 10 | 2018 | 4 | |
| 11 | 2018 | 1 | |
| 12 | 2016 | 6 | |
| 13 | 2015 | 1 | |
| 14 | MAGRIT phase III trial in adjuvant NSCLC: MAGE-A3 gene expression frequency on the first 2150 patients screened and demographics of first patients randomized | 2009 | 2 |
| 15 | 2008 | 6 | |
| 16 | 2008 | 1 | |
| 17 | 2007 | 4 | |
| 18 | 2007 | 47 | |
| 19 | 2007 | 12 | |
| 20 | 2002 | 3 |
About Emilio Esteban
Emilio Esteban is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 161 papers that have together received 4.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (44 papers), Lung Cancer Treatments and Mutations (40 papers), Cancer Immunotherapy and Biomarkers (30 papers), Cancer Genomics and Diagnostics (27 papers), Lung Cancer Research Studies (27 papers), Renal and related cancers (20 papers), Lung Cancer Diagnosis and Treatment (19 papers) and Cancer Treatment and Pharmacology (19 papers). The work is most often cited by research in Oncology (2.3k citations), Pulmonary and Respiratory Medicine (2.6k citations) and Cancer Research (737 citations). Emilio Esteban has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Saulius Cicėnas, Tudor–Eliade Ciuleanu, Barbara Klughammer, Lilia Stelmakh, Erzsébet Juhász, I. Melezínek, Wolfram Brugger, Aleksandra Szczęsna, Olivier Molinier and Gaëlle Klingelschmitt.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.